Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Trigeminal Neuralgia: early-phase trial registry

5 of 10 indexed Trigeminal Neuralgia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 5 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Trigeminal Neuralgia: 10 US clinical trials tracked, 5 recruiting.

Trigeminal Neuralgia is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Minnesota, running 2 of these trials.

Enrollment posture brief

Registry condition trigeminal-neuralgia

OPEN 5 | RECR 50% | LATE 1 | EARLY 3 | RANK #1724 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Acute Leukemia of Ambiguous 80%Trigeminal Neuralgia (this)50%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Trigeminal Neuralgia

Trigeminal Neuralgia lists 5 open slots (50% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Trigeminal Neuralgia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Trigeminal Neuralgia is recruiting above its size-band peers.

    5 of 10 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Trigeminal Neuralgia research.

    University of Minnesota accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Most Trigeminal Neuralgia trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.

  4. Trigeminal Neuralgia research is mostly interventional.

    7 interventional and 3 observational studies make up this index (70% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 41

Open and recent trials

10 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 4 1

Named interventions

Most-linked intervention names on Trigeminal Neuralgia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Basimglurant Drug
1 trials
Low Frequency rTMS Device
1 trials
High Frequency rTMS Device
1 trials
80 Gy Radiation Radiation
1 trials
Unframed Virtual Cone Device
1 trials
Dextromethorphan Drug
1 trials
Trigeminal Electrophysiology Procedure
1 trials
TSEPs recording only Other
1 trials

US sites by state

Facility locations filed on Trigeminal Neuralgia trials. A trial with sites in several states counts in each.

California 3 trials
New York 2 trials
Minnesota 2 trials
Maryland 2 trials
Georgia 2 trials
Florida 2 trials
West Virginia 1 trials
Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Trigeminal Neuralgia page

10 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Trigeminal Neuralgia condition card totals 10 registered trials; most-linked intervention Basimglurant; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.